The US Food and Drug Administration (FDA) has approved an injectable form of dantrolene sodium (Ryanodex, Eagle Pharmaceuticals) for rapid treatment of malignant hyperthermia (MH), along with the ...

Malignant hyperthermia (MH) is a life‐threatening pharmacogenetic disorder of skeletal muscle characterised by a hypermetabolic response to certain anaesthetic agents. Research in this field has ...

Anesthesiologist have created a guide for the transfer of care of malignant hyperthermia patients from ASCs to receiving hospital facilities, according to a study published in the Nov. 2011 issue of ...

Malignant hyperthermia is an uncommon disorder that presents in an ambulatory surgery center utilizing general anesthesia. Preparation for management of this condition needs to be a significant part ...

Malignant hyperthermia crises come on suddenly, and healthcare providers have no real way to predict which patients may experience this reaction while under anesthesia unless they have found a ...

A team of researchers led by Osaka University finds that mutant variants of the calcium channel protein RyR1 are hypersensitive to heat, which creates a positive feedback loop of calcium release and ...

Researchers looked at whether or not it was necessary to stock dantrolene, a drug used to treat malignant hyperthermia, at facilities using succinylcholine alone instead of volatile anesthetics, ...

The benefit event helped raised funds for the Malignant Hyperthermia Association of the United States (MHAUS). Malignant Hyperthermia is a rare, genetic skeletal muscle disease which producer/director ...

A team of researchers has found that mutations in the calcium channel protein RyR1 that confer susceptibility to malignant hyperthermia make the protein hypersensitive to heat, which triggers ...